Our premium diuretic tablets combine Frusemide I.P. 20 Mg and Spironolactone I.P. 50 Mg in a single, film-coated formulation designed for enhanced patient compliance and treatment efficacy. This dual-action therapy provides effective diuresis while minimizing potassium depletion, making it a trusted solution for managing complex fluid retention conditions. Each tablet is manufactured to strict pharmacopeial standards, ensuring consistent dosage, reliability, and predictable therapeutic outcomes for healthcare professionals and their patients. The precise formulation guarantees optimal absorption and bioavailability, supporting effective treatment protocols across various healthcare settings.
These tablets are extensively utilized across hospitals, cardiac care units, nephrology departments, and chronic care facilities. They serve as a foundational treatment for edema associated with congestive heart failure, hepatic cirrhosis, and renal conditions. Medical institutions value this comb...
Our premium diuretic tablets combine Frusemide I.P. 20 Mg and Spironolactone I.P. 50 Mg in a single, film-coated formulation designed for enhanced patient compliance and treatment efficacy. This dual-action therapy provides effective diuresis while minimizing potassium depletion, making it a trusted solution for managing complex fluid retention conditions. Each tablet is manufactured to strict pharmacopeial standards, ensuring consistent dosage, reliability, and predictable therapeutic outcomes for healthcare professionals and their patients. The precise formulation guarantees optimal absorption and bioavailability, supporting effective treatment protocols across various healthcare settings.
These tablets are extensively utilized across hospitals, cardiac care units, nephrology departments, and chronic care facilities. They serve as a foundational treatment for edema associated with congestive heart failure, hepatic cirrhosis, and renal conditions. Medical institutions value this combination for its ability to support comprehensive patient care protocols, especially in cases where potassium conservation is critical alongside effective fluid management. The product meets the demands of healthcare providers who require dependable, evidence-based pharmaceutical solutions that integrate seamlessly into existing treatment regimens and hospital formularies.
For importers and distributors, we offer bulk supply options with comprehensive documentation to ensure seamless integration into your supply chain. Our products come with reliability guarantees and are backed by consistent quality control processes, making them a low-risk, high-value addition to your portfolio. The therapeutic consistency and trusted performance of these tablets provide business partners with a competitive edge in serving medical institutions and pharmacies worldwide. Each batch undergoes rigorous testing to ensure it meets international quality standards, providing assurance to both healthcare providers and supply chain partners.
Key Features:
- Combines Frusemide I.P. 20 Mg and Spironolactone I.P. 50 Mg
- Film-coated tablets for improved patient compliance
- Manufactured to pharmacopeial standards for consistency
- Strict quality control throughout production process
- Comprehensive documentation and compliance support
Benefits:
- Effective dual-action therapy for edema and hypertension
- Potassium conservation reduces need for supplementation
- Consistent therapeutic outcomes across all batches
- Enhanced patient compliance with film-coated formulation
- Reliable bulk supply for healthcare institutions